Table 1.
Unable to Determine (n=11) | Unlikely Related (n=15) | Excluded (n=18) | |
---|---|---|---|
| |||
Age | |||
< 2 years | 8 (73%) | 12 (80%) | 10 (56%) |
2 to < 4 years | 1 (9%) | 1 (7%) | 4 (22%) |
4 to < 6 years | 2 (18%) | 2 (13%) | 4 (22%) |
| |||
Gender | |||
Male | 3 (27%) | 8 (53%) | 11 (61%) |
Female | 5 (46%) | 7 (47%) | 7 (39%) |
Not Reported | 3 (27%) | 0 (0%) | 0 (0%) |
| |||
Death | |||
Fatal | 3 (27%) | 12 (80%) | 0 (0%) |
Non-Fatal | 8 (73%) | 3 (20%) | 18 (100%) |
| |||
Drug Administered by | |||
Parent | 5 (46%) | 6 (40%) | 8 (44%) |
Other | 3 (27%) | 6 (40%) | 5 (28%) |
Self | 0 (0%) | 1 (7%) | 4 (22%) |
Healthcare Facility | 1 (9%) | 1 (7%) | 0(0%) |
Not Reported | 2 (18%) | 1 (7%) | 1 (6%) |
| |||
Exposure Site | |||
Home | 2 (18%) | 3 (20%) | 12 (67%) |
Healthcare Facility | 1 (9%) | 1 (7%) | 0 (0%) |
Other Residence | 0 (0%) | 2 (13%) | 0 (0%) |
Not Reported | 8 (73%) | 9 (60%) | 6 (33%) |
| |||
Reason for Exclusion | |||
No Hepatic Event | N/A | N/A | 16 (89%) |
Acute Overdose | 2 (11%) | ||
| |||
Alternative Causes | |||
Underlying Illness/Condition | 9 (60%) | ||
Exposure to Non-APAP Product | N/A | 3 (20%) | N/A |
Inconsistent Clinical Course | 2 (13%) | ||
Asphyxia Due to Overlay | 1 (7%) |